Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin superfamily member 1 is a plasma membrane glycoprotein encoded by the IGSF1 gene on the human X chromosome[2]. This protein contains multiple immunoglobulin-like domains and is a member of the large immunoglobulin superfamily, which is characterized by cell-surface and soluble proteins involved in recognition, binding, or adhesion of cells[8]. Functionally, IGSF1 is thought to act as a coreceptor in inhibin signaling, although it is not a high-affinity inhibin receptor, and may antagonize activin A signaling in some contexts[7]. The protein is mainly expressed in the pituitary gland and brain and is crucial for normal endocrine function, especially in regulating thyroid-stimulating hormone (TSH) secretion. Mutations in IGSF1 disrupt trafficking and function of the protein, resulting in central hypothyroidism, testicular enlargement, and delayed puberty in males. Females are rarely clinically affected. There is currently no direct drug targeting IGSF1, but its deficiency is a key biomarker for the diagnosis and management of congenital central hypothyroidism[2][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin superfamily member 1 (IGSF1).